[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 20, 1949

TREATMENT OF A PATIENT WITH A PHEOCHROMOCYTOMAUse of an Adrenolytic Drug Before and During Operation

Author Affiliations

Durham, N. C.
From the Departments of Surgery and Pediatrics, Duke University School of Medicine.; United States Public Health research fellow in surgery (Dr. Longino). Aided by a grant from the American Foundation for High Blood Pressure.

JAMA. 1949;140(16):1273-1274. doi:10.1001/jama.1949.82900510003006a
Abstract

Since Goldenberg, Snyder and Aranow1 reported their experiences using 2-(1-piperidylmethyl)-1,4-benzodioxan (933 F) in the diagnosis of hypertension caused by circulating epinephrine liberated from functioning tumors of the adrenal medulla, many have confirmed their results. Possibility of failure and value of other tests have been reviewed by Roth and Kvale.2 It is well known that pheochromocytomas, whether associated with paroxysmal or persistent hypertension, are removed with difficulty because anesthetic agents and operative manipulation often cause excessive elevations or fluctuations of blood pressure and subsequent reduction and shock. The present high surgical mortality rate (3 of 20 operations reported in the literature since 1943, as reviewed by Hatch, Richards and Spiegl3) is attributed to epinephrine intoxication. Injection of epinephrine can cause increase or decrease of blood pressure. Also, tumors may contain epinephrine or non-epinephrine.4 Behavior of a patient who has a pheochromocytoma with circulating epinephrine and who is

First Page Preview View Large
First page PDF preview
First page PDF preview
×